SecBot SecBot
SECBOTREPLAY Home › Report › REGN

REGN · Director Huda Zoghbi filed a Form 144 notice of intent to sell 7,439…

REGENERON PHARMACEUTICALS, INC. · 144 filed Nov 3, 2026 at 16:15 ET

At the news

NEUTRALIMPACT 2/10

144 filed Nov 3, 2026 at 16:15 ET

Director Huda Zoghbi filed a Form 144 notice of intent to sell 7,439 shares of Regeneron common stock, with an estimated aggregate market value of approximately $7.22 million based on the filing date. The shares were acquired through a stock option exercise on the same day, and the sale is planned for cash on the open market.

  • Filer: Huda Zoghbi, a director of Regeneron Pharmaceuticals
  • Shares to be sold: 7,439 shares of common stock
  • Estimated aggregate market value: $7,219,262.83
  • Shares acquired on 11/03/2026 via stock option exercise from the company

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access